Queen Mary University of London

University / College


Location: London, United Kingdom (GB) GB

ISNI: 0000000121711133

ROR: https://ror.org/026zzn846

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial (2022) Azizi M, Mahfoud F, Weber MA, Sharp ASP, Schmieder R, Lurz P, Lobo MD, et al. Journal article Neoadjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy, followed by adjuvant pembrolizumab versus placebo for early-stage TNBC: Event-free survival sensitivity and subgroup analyses from KEYNOTE-522 (2022) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur H, Kuemmel S, Bergh J, et al. Conference contribution Prevalence of sport injuries in Olympic combat sports: a cross-sectional study examining one Olympic period (2022) Lambert C, Ritzmann R, Lambert S, Lachmann D, Malliaropoulos NG, Gesslein M, Peters N, Shafizadeh S Journal article The End of Informal E-waste Recycling in Accra, Ghana? (2022) Seidu F, Kaifie A Journal article Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trial (2022) Rader F, Kirtane AJ, Wang Y, Daemen J, Lurz P, Sayer J, Saxena M, et al. Journal article A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy (2022) Buettner FA, Winter S, Stuehler V, Rausch S, Hennenlotter J, Füssel S, Zastrow S, et al. Journal article HRQoL with neoadjuvant pembrolizumab plus chemotherapy vs placebo plus chemotherapy, followed by adjuvant pembrolizumab vs placebo for early-stage TNBC: Results from KEYNOTE-522 (2022) Dent RA, Cortes J, Pusztai L, Mcarthur HL, Kuemmel S, Bergh J, Denkert C, et al. Conference contribution Disease stability over 5 years in people with multiple sclerosis treated with cladribine tablets: a plain language summary of publication (2022) Giovannoni G, Comi G, Rammohan K, Rieckmann P, Dangond F, Jack D, Vermersch P Journal article Automatic 3D+t four-chamber CMR quantification of the UK biobank: integrating imaging and non-imaging data priors at scale (2022) Xia Y, Chen X, Ravikumar N, Kelly C, Attar R, Aung N, Neubauer S, et al. Journal article The Challenging Management of Craniopharyngiomas in Adults: Time for a Reappraisal? (2022) Cuny T, Buchfelder M, Dufour H, Grossman A, Gatta-Cherifi B, Jouanneau E, Raverot G, et al. Journal article, Review article